Global Diagnostic Imaging Systems Market Report 2020: Industry Dynamics and Competitive Benchmarking to 2030

March 15, 2021

Global Diagnostic Imaging Systems Market Report: Generated $38.9 billion in 2019 and will increase to $70.0 billion in 2030.

Factors such as the escalating healthcare expenditure, burgeoning number of diagnostic imaging centers, growing requirement for diagnostic imaging procedures, booming population of the elderly, continuous technological developments in diagnostic imaging, and rising prevalence of chronic diseases are expected to drive the diagnostic imaging systems market at a CAGR of 5.8% during the forecast period (2020-2030).

One of the leading factors supporting the diagnostic imaging systems market growth is the surge in the geriatric population. According to the World Population Ageing report of 2019 of the United Nations (UN), the population of people aged 65 years and above is expected to reach nearly 1.5 billion in 2050. Older people need extensive care, as they are more susceptible to chronic diseases due to their weak immunity levels. Due to this, the demand for diagnostic imaging systems will continue to escalate during the forecast period.

Currently, the diagnostic imaging systems market is witnessing the trend of product launches. The new high-quality imaging systems are facilitating access to advanced diagnosis with fast and accurate results. For instance, Carestream Health Inc. launched the DRX-Compass X-ray System in August 2020 to provide a scalable and flexible approach to digital imaging. The system, marketed to diagnostic imaging centers and hospitals, assists in vertical auto-centering and auto-tracking. Similarly, in July 2020, Hologic Inc. launched a cart-based system ultrasound system, named SuperSonic MACH 40, in the U.S. to offer a high image quality and various imaging modes.

Key Topics Covered:

Chapter 1. Research Background

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 X-ray imaging systems

4.1.1.1.1 By technology

4.1.1.1.1.1 Digital

4.1.1.1.1.2 Analog

4.1.1.1.2 By portability

4.1.1.1.2.1 Stationary

4.1.1.1.2.2 Portable

4.1.1.2 MRI systems

4.1.1.2.1 By type

4.1.1.2.1.1 Closed

4.1.1.2.1.2 Open

4.1.1.2.2 By field strength

4.1.1.2.2.1 Mid

4.1.1.2.2.2 High

4.1.1.2.2.3 Low

4.1.1.3 Ultrasound systems

4.1.1.3.1 By technology

4.1.1.3.1.1 3D and 4D

4.1.1.3.1.2 2D

4.1.1.3.1.3 Doppler imaging

4.1.1.3.2 By portability

4.1.1.3.2.1 Trolley/cart-based

4.1.1.3.2.2 Compact/portable

4.1.1.4 CT scanners

4.2.2.1.1 By slice

4.1.1.5 Nuclear imaging systems

4.1.1.6 Others

4.1.2 By Application

4.1.2.1 Cardiology

4.1.2.2 Oncology

4.1.2.3 Neurology

4.1.2.4 Orthopedics

4.1.2.5 Urology

4.1.2.6 Dentistry

4.1.2.7 Ophthalmology

4.1.2.8 OB/GYN

4.1.2.9 Others

4.1.3 By End User

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing number of product launches

4.2.1.2 Rising number of collaborations and acquisitions

4.2.2 Drivers

4.2.2.1 Increasing number of healthcare settings

4.2.2.2 Increasing healthcare expenditure

4.2.2.3 Growing need for diagnostic imaging procedures

4.2.2.4 Surge in the prevalence of chronic diseases

4.2.2.5 Technological advancements in diagnostic imaging

4.2.2.6 Surging geriatric population

4.2.2.7 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of development and maintenance of diagnostic imaging systems

4.2.3.2 Stringent regulations

4.2.3.3 Diminishing helium reserves

4.2.3.4 Increasing risk of cancer due to exposure to radiation

4.2.3.5 Impact analysis of restraints on market forecast

4.3 Porter’s Five Forces Analysis

4.4 Impact of COVID-19

4.5 Regulatory Scenario for Diagnostic Imaging Systems

4.6 Pricing Analysis

4.7 Maintenance Cost Associated with Diagnostic Imaging Systems

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.1.1 X-Ray Imaging Systems Market

5.1.1.1 By technology

5.1.1.2 By portability

5.1.2 MRI Systems Market

5.1.2.1 By type

5.1.2.2 By field strength

5.1.3 Ultrasound Systems Market

5.1.3.1 By technology

5.1.3.2 By portability

5.1.4 CT Scanners Market

5.1.4.1 By slice

5.2 By Application

5.3 By End User

5.4 By Region

Chapter 6. North America Market Size and Forecast

Chapter 7. Europe Market Size and Forecast

Chapter 8. APAC Market Size and Forecast

Chapter 9. LATAM Market Size and Forecast

Chapter 10. MEA Market Size and Forecast

Chapter 11. Competitive Landscape

11.1 Market Share Analysis of Key Players

11.2 Competitive Benchmarking

11.3 Strategic Developments of Key Players

11.3.1 Product Launches and Approvals

11.3.2 Acquisitions

11.3.3 Partnerships

11.3.4 Other Developments

Chapter 12. Company Profiles

  • General Electric Company
  • Siemens AG
  • Koninklijke Philips N.V.
  • Dragerwerk AG & Co. KGaA
  • FUJIFILM Holdings Corporation
  • Hitachi Ltd.
  • Agfa-Gevaert N.V.
  • Canon Inc.
  • Carestream Health Inc.
  • Shimadzu Corporation
  • Esaote S.p.A.
  • Mindray Bio-Medical Electronics Co. Ltd.
  • Analogic Corporation
  • Samsung Electronics Co. Ltd.
  • Hologic Inc.
  • Konica Minolta Inc.
  • KARL STORZ SE & Co. KG
  • DEL MEDICAL Inc.
  • Dornier MedTech GmbH
  • Varex Imaging Corporation
  • Bruker Corporation
  • Fonar Corporation
  • Neusoft Corporation
  • Aurora Healthcare US Corp
  • Time Medical Holding
  • Aspect Imaging Ltd.
  • SonoScape Medical Corporation
  • SternMed GmbH

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version